1-5 of 5
George J. Weiner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B002: Vidutolimod, an immunostimulatory virus-like particle, reduces proliferation but enhances the activation of tumor-specific T cells

Free
Travis D. Fischer, Caitlin Lemke-Miltner, George J. Weiner
Journal: Cancer Immunology Research
Cancer Immunol Res (2023) 11 (12_Supplement): B002.
https://doi.org/10.1158/2326-6074.TUMIMM23-B002
Published: 01 December 2023
View articletitled, Abstract B002: Vidutolimod, an immunostimulatory virus-like particle, reduces proliferation but enhances the activation of tumor-specific T cells
Journal Articles

A Genetic Screen to Identify Gain- and Loss-of-Function Modifications that Enhance T-cell Infiltration into Tumors

Available to Purchase
Laura M. Rogers, Zhaoming Wang, Sarah L. Mott, Adam J. Dupuy, George J. Weiner
Journal: Cancer Immunology Research
Cancer Immunol Res (2020) 8 (9): 1206–1214.
https://doi.org/10.1158/2326-6066.CIR-20-0056
Published: 01 September 2020
View articletitled, A Genetic Screen to Identify Gain- and Loss-of-Function Modifications that Enhance T-cell Infiltration into Tumors
Open the PDF for A Genetic Screen to Identify Gain- and Loss-of-Function Modifications that Enhance T-cell Infiltration into Tumors in another window
Includes: Supplementary data
Journal Articles

Abstract A51: Rationally improving T cell-mediated cancer immunotherapies using Sleeping Beauty mutagenesis to identify novel therapeutic targets

Free
Laura M. Rogers, Adam J. Dupuy, George J. Weiner
Journal: Cancer Immunology Research
Cancer Immunol Res (2020) 8 (4_Supplement): A51.
https://doi.org/10.1158/2326-6074.TUMIMM18-A51
Published: 01 April 2020
View articletitled, Abstract A51: Rationally improving T cell-mediated cancer immunotherapies using Sleeping Beauty mutagenesis to identify novel therapeutic targets
Journal Articles

An RNA Aptamer–Based Biomarker Platform Demonstrates High Soluble CD25 Occupancy by IL2 in the Serum of Follicular Lymphoma Patients

Available to Purchase
Suresh Veeramani, Sue E. Blackwell, William H. Thiel, Zhi-Zhang Yang, Stephen M. Ansell, Paloma H. Giangrande, George J. Weiner
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (9): 1511–1522.
https://doi.org/10.1158/2326-6066.CIR-18-0821
Published: 03 September 2019
View articletitled, An RNA Aptamer–Based Biomarker Platform Demonstrates High Soluble CD25 Occupancy by IL2 in the Serum of Follicular Lymphoma Patients
Open the PDF for An RNA Aptamer–Based Biomarker Platform Demonstrates High Soluble CD25 Occupancy by IL2 in the Serum of Follicular Lymphoma Patients in another window
Includes: Supplementary data
Journal Articles

Three Steps to Breaking Immune Tolerance to Lymphoma: A Microparticle Approach

Available to Purchase
Amani Makkouk, Vijaya B. Joshi, Caitlin D. Lemke, Amaraporn Wongrakpanich, Alicia K. Olivier, Sue E. Blackwell, Aliasger K. Salem, George J. Weiner
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (4): 389–398.
https://doi.org/10.1158/2326-6066.CIR-14-0173
Published: 05 April 2015
View articletitled, Three Steps to Breaking Immune Tolerance to Lymphoma: A Microparticle Approach
Open the PDF for Three Steps to Breaking Immune Tolerance to Lymphoma: A Microparticle Approach in another window
Includes: Supplementary data